Disease / condition

Carotid Artery Stenosis clinical trials

Free access to 49 studies·10+ countries·Updated daily8 recruiting
49
Total trials
10+
Countries
10+
Sponsors
8
Recruiting
By phase
N/A31
Phase 46
Phase 35
Phase 24
Not Applicable3
By status
Completed20
Unknown9
Recruiting8
Not yet recruit...8
Terminated2
Top countries
China14
United States of America14
Japan2
Netherlands2
France2
Top sponsors
W.L.Gore & Associa...2
Lumen Biomedical2
Stanford Universit...2
University of Belg...2
Weifang Medical Un...2
Recent trials
Latest clinical trials for Carotid Artery Stenosis
NCT06398223Recruiting
Ocular Perfusion in Patients With Unilateral Carotid Artery Stenosis
Medical University of ViennaAustria
NCT06365697Not yet recr...
Evaluation of the Ton-bridge Carotid Stent for Carotid Artery Stenosis
Zhuhai Tonbridge Medical Tech....China
NCT06033963Recruiting
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Carotid Artery Stenosis Receiving Carotid EndArterectomy
Yi YangChina
NCT05451030Recruiting
Effect of Remote Ischemic Preconditioning on Cerebral Circulation Time in Patients With Severe Carotid Artery Stenosis (RIP-CCT)
General Hospital of Shenyang M...China
NCT05629000Recruiting
Optimization Strategy of Carotid Artery Stenosis
Peking Union Medical College H...China
NCT05293067Not yet recr...
Troponin In Carotid Revascularization
University of BelgradeSerbia
NCT05270005Not yet recr...
Progression Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound Flow Imaging
Rijnstate HospitalNetherlands
ChiCTR2100051679·Not ApplicableNot yet recr...
Untitled Trial
Beijing Huaxin Hospital (The F...China
ChiCTR2100051570·Not ApplicableNot yet recr...
Untitled Trial
Beijing Huaxin Hospital (The F...China
ChiCTR2100049668Not yet recr...
Untitled Trial
Weifang Medical UniversityChina
ChiCTR2100049621Not yet recr...
Untitled Trial
Weifang Medical UniversityChina
NCT04900844Recruiting
Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
InspireMDUnited States of America
NCT04651998Recruiting
Effect of Carotid Artery Stent on Evoked Cerebral Blood Oxygenation and Neurocognitive Functioning
Shanghai Jiao Tong University ...China
ChiCTR2000029300Not yet recr...
Untitled Trial
Department of Neurology, West ...China
NCT04142541Completed
Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis
Contego Medical, Inc.Germany,Italy
NCT03996148·Phase 4Completed
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
The Cooper Health SystemUnited States of America
NCT03931161·Phase 4Recruiting
Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1)
Imperial College Healthcare NH...United Kingdom
NCT03816202Completed
Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)
Integra LifeSciences Corporati...United States of America
NCT03495830
Stratification of Patient With Carotid Disease
University of BelgradeGermany,Netherlands,Serbia,Spain
NCT03504228Completed
Prospective Single Arm CAS - ROADSAVER Study
Terumo Europe N.V.Belgium,Czech,France,Germany,Hungary,Latvia,Netherlands,North Macedonia,Poland,Portugal,Serbia,Slova
About this record

Access comprehensive clinical trial information for Carotid Artery Stenosis through Pure Global AI's free database. This collection includes 49 clinical trials across multiple phases including N/A, Phase 4, Phase 3. Currently, 8 trials are actively recruiting participants.

Research for Carotid Artery Stenosis is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include W.L.Gore & Associates and Lumen Biomedical. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 49 clinical trials studying Carotid Artery Stenosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include W.L.Gore & Associates, Lumen Biomedical, Stanford University, among others.